Seeing Is Believing
CKPT is currently covered by 4 analysts with an average price target of $6.95. This is a potential upside of $2.85 (69.51%) from yesterday's end of day stock price of $4.1.
Checkpoint Therapeutics's activity chart (see below) currently has 5 price targets and 38 ratings on display. The stock rating distribution of CKPT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 6.67% with an average time for these price targets to be met of 62.33 days.
Highest price target for CKPT is $4.1, Lowest price target is $4.1, average price target is $4.1.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 11-Mar-2025. First documented stock forecast 08-Dec-2017.
Currently out of the existing stock ratings of CKPT, 22 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4.1
$0.06 (1.49%)
1 months 14 days ago
(11-Mar-2025)
0/4 (0%)
$0.1 (2.50%)
Buy
$4.1
$0.06 (1.49%)
$7
1 months 15 days ago
(10-Mar-2025)
1/5 (20%)
$0.12 (3.02%)
187
Buy
1 years 8 months 10 days ago
(15-Aug-2023)
0/2 (0%)
$8.34 (125.23%)
What is CKPT (Checkpoint Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CKPT (Checkpoint Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CKPT (Checkpoint Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CKPT (Checkpoint Therapeutics)?
Which analyst is the currently most bullish on CKPT (Checkpoint Therapeutics)?
Which analyst is the currently most reserved on CKPT (Checkpoint Therapeutics)?